Navigation Links
ViroPharma Incorporated Honored by the National Organization for Rare Disorders
Date:5/18/2009

mpeting product which has been granted orphan drug designation thereby preventing Cinryze from reaching the market for acute treatment of HAE. These factors, and other factors, including, but not limited to those described in ViroPharma's annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission during 2009, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. ViroPharma Provides 2008 Outlook
3. ViroPharma to Present at the BIO CEO & Investor Conference
4. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
5. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
6. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
7. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
8. ViroPharma to Present at Two Upcoming Healthcare Conferences
9. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
10. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
11. ViroPharma To Acquire Lev Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...rstCall/--ArenaPharmaceuticals,Inc.(Nasdaq: ARNA )...atthePiperJaffray21stAnnualHealthCareConferenceonD...cTime)attheNewYorkPalaceHotelinNewYorkCity.JackLie...eduledtoprovideanoverviewofthecompany,includingits...veaudiowebcastofthepresentationwillbeavailableunde...
(Date:11/24/2009)...--HealthRoboticstodayannounced,thatithasformedanew....ThisrecentlyformedToronto-basedcompanywilloperate...t,install,andsupport,HealthRobotics,i.v.RoomoftheF...offeringsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM).,...nan"asneeded,basis"toitsstrategicpartnershipswithM...
(Date:11/24/2009)...ts Service (CAS), the global expert on chemical in...ow the world,s leading producer of patent inventio... patent office, the World Intellectual Property Or...d Trademark Office (USPTO) for more than a decade,...xceeded Japan for the first time on a monthly basi...
(Date:11/23/2009)...vocative new study, a University of Utah scientist...major cause of global warming cannot be stabilize...builds the equivalent of one new nuclear power pla...ll be any substantial near-term departure from rec...sion rates," says the new paper by Tim Garrett, an...
Breaking Biology Technology:Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...URY, N.J., Feb. 1 Amicus Therapeutics,Inc. (Nasda...President and,Chief Executive Officer, will presen...harmaceutical, Biotechnology & Medical Device Conf...08 at 11:40 am (Eastern Standard,Time) at the Gran...live and may be accessed by visiting,Amicus, websi...
... SAN FRANCISCO, Calif., Jan. 31 Rigel,Pharmaceuti...icing of its,public offering of 5,000,000 shares o... of the shares are being offered by Rigel. The und...tional 750,000 shares to cover,over-allotments, if...y 6,2008, subject to the satisfaction of customary...
...AM, Mass., Jan. 31 Inverness Medical,Innovations,...rketer of rapid,diagnostic products for the consum...it will attend the upcoming 2008 Merrill Lynch Glo...ce Conference being held,February 5 through 7, 200...wanziger, Chief Executive Officer, and Jon Russell...
Other Biology Technology:Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 3Rigel Announces Pricing of Public Offering of Common Stock 2Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008 2
(Date:11/23/2009)...ccine available for the H1N1 virus has been sent t...The vaccination marks the first time vaccine has b...ic flu., Iowa State University,s Hank Harris, pr...his summer and has been shipping preventive doses ...r several weeks., The latest vaccines were shipp...
(Date:11/23/2009)...- A USDOE and USDA study concluded that 50 million...nd pasture could be converted from current uses to...chgrass, from which biomass could be harvested for...roduction of a perennial grass monoculture from wh...annually is expected to require nitrogen fertilize...
(Date:11/23/2009)...w Hampshire microbiologist Louis Tisa has received...ding of the actinorhizal plants, widespread woody ...contaminated soils. , The United States Departm...r of molecular, cellular and biomedical sciences, ...ween the bacteria Frankia and Casuarina, an actino...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Exercise helps patients with non alcoholic fatty liver disease 50560 1Exercise helps patients with non alcoholic fatty liver disease 50560 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 1Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 3Two New Dakim Sponsored Blogs Help Families Affected by Dementia 50554 1Two New Dakim Sponsored Blogs Help Families Affected by Dementia 50554 2
...l team of scientists from Canada (Universit Laval)...) and Spain (Do ana Biological Station), have disc...ast African cichlid fishes a group of fish whose ...ed evolutionary biologists for decades evolved di...n why they do not interbreed, despite living side ...
...-legged animals sprouted fingers and toes, they to...he cooking time, say University of Florida scienti...S ONE. , Even sharks which have existed for mo...ingers in their genetic cookbook not to eat them,...ms of development in shark embryos, UF scientists ...
... diet high in red meat, fatty products, refined gr...be increasing their chance of disease relapse and ...cer Institute. , The study, published in the Aug....ssociation, involved 1,009 patients with stage III...ery and chemotherapy. Stage III colon cancer is ch...
Other Biology News:Adaptation to parasites drive African fishes along different evolutionary paths 2Conquest of land began in shark genome 2Conquest of land began in shark genome 3'Western' diet linked to increased risk of colon cancer recurrence 2
... Protein (PEBP) does not share significant homolog...expressed in the central nervous system, spleen, t...role PEBP is involved in is exerting inhibitory ac...thrombin, neuropsin, and chymotrypsin. Serine pro...
TriContinentMultiWash III from Femto Scientific
MitoCapture Apoptosis Detection Kit from BioVision
H2A.X Phosphorylation Assay Kit (Chemiluminescence Detection) from Upstate
Biology Products: